MONTANOVA CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001569064

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2025 · 97 positions · Total reported value $3.24B · Top-10 concentration 46.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.3% · 21 new · 17 cut · 14 exited

Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2025 13F filing, MONTANOVA CAPITAL, LLC disclosed 97 equity positions with a combined reported value of $3.24B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 46.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were SPY ($432.50M), ARQT ($161.73M), IWM ($151.59M). By sector, the heaviest allocations are Health Care 39.0%, Technology 16.9%. Versus the prior quarter, allocation shifted toward Other (+6.6pp), Consumer Staples (+1.6pp) and away from Consumer Discretionary (-1.5pp), Health Care (-8.1pp).

Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 77% of names.

The largest new positions opened in Q2 2025 were IWM ($151.59M), DKS ($51.52M), GEHC ($39.43M).

Of the 14 positions fully exited versus the prior quarter, the largest were ITCI ($92.46M), CMG ($27.09M), SNOW ($20.15M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • IWM ISHARES TR · $151.59M
  • DKS DICKS SPORTING GOODS INC · $51.52M
  • GEHC GE HEALTHCARE TECHNOLOGIES I · $39.43M
  • CMPX COMPASS THERAPEUTICS INC · $18.59M
  • PINS PINTEREST INC · $15.42M
  • KYMR KYMERA THERAPEUTICS INC · $12.00M
  • TSHA TAYSHA GENE THERAPIES INC · $7.43M
  • REGN REGENERON PHARMACEUTICALS · $4.53M

Fully Exited (vs previous quarter)

  • ITCI INTRA-CELLULAR THERAPIES INC · prev qtr: $92.46M
  • CMG CHIPOTLE MEXICAN GRILL INC · prev qtr: $27.09M
  • SNOW SNOWFLAKE INC · prev qtr: $20.15M
  • TTWO TAKE-TWO INTERACTIVE SOFTWAR · prev qtr: $15.00M
  • RBLX ROBLOX CORP · prev qtr: $13.27M
  • U UNITY SOFTWARE INC · prev qtr: $6.65M
  • BIOA BIOAGE LABS INC · prev qtr: $5.46M
  • SNY SANOFI SA · prev qtr: $4.64M

Insider Transactions (Form 4)

Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-20 Opt exercise Veradermics, Inc 151,000 — SEC filing
2026-08-20 Opt exercise Veradermics, Inc 149,000 — SEC filing
2026-08-19 Sell Veradermics, Inc 59,399 $107.25 SEC filing
2026-08-19 Sell Veradermics, Inc 690,601 $107.25 SEC filing

All insider transactions →

Fund Profile

Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79962 (status: Approved), registered 2014-06-26
  • Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: montanova.com

Portfolio Structure

  • 96 positions · $5.47B reported value (Q2 2026)
  • Top 10 holdings = 49.1% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
  • Average position size: $56.96M

Sector Tilt

  • Health Care 50.9%
  • Information Technology 14.5%
  • Consumer Discretionary 8.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
  • 32 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 39.0%
Technology 16.9%
Financials 5.0%
Other 25.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 700.00K $432.50M 13.36%
13.36%
Add
2 11.54M $161.73M 4.99%
4.99%
Add
3 702.50K $151.59M 4.68%
4.68%
New
4 14.21M $139.54M 4.31%
4.31%
Reduce
5 3.77M $133.94M 4.14%
4.14%
Add
6 169.84K $125.36M 3.87%
3.87%
Reduce
7 9.88M $115.56M 3.57%
3.57%
Hold
8 1.23M $87.25M 2.69%
2.69%
Add
9 2.28M $82.83M 2.56%
2.56%
Add
10 310.26K $79.86M 2.47%
2.47%
Add
11 5.62M $79.30M 2.45%
2.45%
Hold
12 499.56K $78.93M 2.44%
2.44%
Add
13 3.41M $74.30M 2.29%
2.29%
Add
14 300.40K $68.04M 2.10%
2.10%
Reduce
15 12.03M $64.72M 2.00%
2.00%
Add
16 6.80M $64.03M 1.98%
1.98%
Hold
17 428.46K $60.79M 1.88%
1.88%
Add
18 398.80K $56.59M 1.75%
1.75%
Reduce
19 257.62K $56.52M 1.75%
1.75%
Reduce
20 4.96M $56.02M 1.73%
1.73%
Add
21 260.46K $51.52M 1.59%
1.59%
New
22 230.73K $50.44M 1.56%
1.56%
Add
23 2.88M $49.82M 1.54%
1.54%
Add
24 98.83K $49.16M 1.52%
1.52%
Reduce
25 130.72K $47.93M 1.48%
1.48%
Add
26 8.12M $46.83M 1.45%
1.45%
Add
27 927.19K $43.87M 1.35%
1.35%
Add
28 194.16K $41.31M 1.28%
1.28%
Reduce
29 189.66K $41.30M 1.27%
1.27%
Add
30 532.28K $39.43M 1.22%
1.22%
New
31 353.56K $37.98M 1.17%
1.17%
Add
32 5.08M $34.97M 1.08%
1.08%
Hold
33 174.70K $34.51M 1.07%
1.07%
Add
34 3.69M $30.03M 0.93%
0.93%
Add
35 92.36K $29.34M 0.91%
0.91%
Reduce
36 4.37M $27.37M 0.84%
0.84%
Add
37 238.78K $24.03M 0.74%
0.74%
Reduce
38 178.83K $24.02M 0.74%
0.74%
Reduce
39 1.74M $23.60M 0.73%
0.73%
Add
40 68.00K $21.21M 0.66%
0.66%
Add
41 132.79K $20.28M 0.63%
0.63%
Add
42 151.89K $19.08M 0.59%
0.59%
Add
43 7.15M $18.59M 0.57%
0.57%
New
44 14.50M $18.42M 0.57%
0.57%
Add
45 219.18K $17.35M 0.54%
0.54%
Add
46 24.11K $17.06M 0.53%
0.53%
Reduce
47 714.46K $16.10M 0.50%
0.50%
Hold
48 430.02K $15.42M 0.48%
0.48%
New
49 2.68M $15.20M 0.47%
0.47%
Reduce
50 3.36M $15.15M 0.47%
0.47%
Add

FAQ

What did MONTANOVA CAPITAL, LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, MONTANOVA CAPITAL, LLC reported 97 equity positions worth $3.24B in aggregate; its largest disclosed positions were SPY ($432.50M), ARQT ($161.73M), IWM ($151.59M).

How large is MONTANOVA CAPITAL, LLC's portfolio?

MONTANOVA CAPITAL, LLC reported $3.24B of long equity holdings across 97 positions as of 2025-Q2. Top-10 holdings account for 46.6% of reported value.

What is MONTANOVA CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/montanova-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →